Assessing the subjective effects of stimulants in casual users. A methodology and preliminary results.
In order to assess the subjective effects of nefopam, a new non-opiate analgesic, a study was designed using highly educated, young, middle-to-upper class subjects in a naturalistic setting. Results suggest that the design is capable of differentiating variations in subjective drug effects. On a number of measures, 10 mg of d-amphetamine, a modest dosage, could be distinguished from placebo, showing changes in the direction expected for stimulant drugs. Nefopam (90 mg), on the other hand, showed few differences from placebo or caffeine (300 mg). Nefopam appeared mildly dysphoric, rather than stimulant, in subjective effects.
D000328:Adult; D001007:Anxiety / Q000139:chemically induced; D002110:Caffeine / Q000494:pharmacology; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D003863:Depression / Q000139:chemically induced; D003913:Dextroamphetamine / Q000494:pharmacology; D004644:Emotions / Q000187:drug effects; D005059:Euphoria / Q000187:drug effects; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D013287:Illicit Drugs / Q000494:pharmacology*; D008297:Male; D009340:Nefopam / Q000494:pharmacology; D010600:Pharmacology; D010919:Placebos; D013997:Time Factors
D000697:Central Nervous System Stimulants; D013287:Illicit Drugs; D010919:Placebos; D002110:Caffeine; D009340:Nefopam; D003913:Dextroamphetamine